Robert Herpen is an Online Content Editor at Healio. He specializes in the medical field, focusing on topics such as psychiatry, mental health, consumer health, and the regulation of cannabis, including Cannabidiol (CBD). Herpen's work has been recognized with a regional AP award for Best Spot News, and he is featured in Healio.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Robert Herpen's articles predominantly revolve around scientific and healthcare topics such as epilepsy, medical cannabis, seizure reduction, mental health, and treatment options. His coverage attributes indicate a reliance on data and press releases.
To effectively reach out to Robert with pitches or expertise in these areas would be ideal. He seems interested in evidence-based information supported by credible data sources. If you have access to relevant research findings or can provide expert insights into the latest developments within these fields, it could be valuable for his coverage.
Considering his focus on the United States, providing insights related to this geographic area might also enhance your pitch's relevance to him.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Robert Herpen, Pablo Villoslada Md
The question of whether invasive or noninvasive methods provide the best possible outcomes for patients with neurodegenerative conditions persists for researchers. A collaboration between Openwater Health, a San Francisco-based medical technology firm, and a Barcelona-based hospital seeks to provide a clear answer by conducting pilot trials with the former’s version of open low-intensity focused
By: Shenaz Bagha, Robert Herpen
Individuals with a rare form of epilepsy treated with fenfluramine experienced significantly greater seizure reduction as well as clinically meaningful
By: Robert Herpen, Shenaz Bagha
Participation in New York State's medical cannabis program was linked to reduced prescription opioid receipt and reduced opioid exposure at 18 months
By: Richard Gawel, Robert Herpen
Older adults who followed a structured health-related intervention experienced improved sleep-apnea related outcomes compared with those who followed a self-guided intervention, according to data presented at CTAD.
By: Shenaz Bagha, Robert Herpen
Five-point increases in Brain Care Scores were associated with greater reductions in stroke risks among older Black adults compared with older white adults, according to research published in Neurology
By: Robert Herpen, Shenaz Bagha
Adherence to a structured lifestyle intervention was nonsuperior to a self-guided intervention regarding impact on Alzheimer's disease-related
By: Shenaz Bagha, Robert Herpen
The rate of alcohol-related hospitalizations in the U.S. stabilized between 2016 and 2022, but mortality rates, length of stay and total health care costs all increased, according to data published in JAMA Network Open
The FDA has accepted an investigational new drug application for an investigational and proprietary combination therapy to treat frontotemporal dementia, according to a release from the manufacturer.“Frontotemporal dementia (FTD) is a devastating progressive neurodegenerative disorder worsening over time, leading to severe changes in behavioral, personality, language and memory
By: Robert Herpen
Older adults who adhered to a structured lifestyle intervention saw greater improvement from blood flow and regulation mechanisms in both the brain and heart at 2 years than those who used a self-guided intervention, , data show.“Multiple lines of evidence highlight the importance of vascular contributions to cognitive impairment and dementia,” Tina Brinkley, PhD, associate professor
By: Jonathan R. Doty, Shenaz Bagha, Robert Herpen
Key takeaways: The impact of early disease is prompting more aggressive therapies. BTK inhibitors may offer more targeted options for progressive forms of MS.
